Modelling acrylamide acute neurotoxicity in zebrafish larvae

Eva Prats, Cristian Gómez-Canela, Shani Ben-Lulu, Tamar Ziv, Francesc Padrós, Daniel Tornero, Natàlia Garcia-Reyero, Romà Tauler, Arie Admon, Demetrio Raldúa

Research output: Contribution to journalArticleResearchpeer-review

22 Citations (Scopus)


© 2017 The Author(s). Acrylamide (ACR), a type-2 alkene, may lead to a synaptopathy characterized by ataxia, skeletal muscles weakness and numbness of the extremities in exposed human and laboratory animals. Currently, only the mildly affected patients undergo complete recovery, and identification of new molecules with therapeutic bioactivity against ACR acute neurotoxicity is urgently needed. Here, we have generated a zebrafish model for ACR neurotoxicity by exposing 5 days post-fertilization zebrafish larvae to 1 mM ACR for 3 days. Our results show that zebrafish mimics most of the pathophysiological processes described in humans and mammalian models. Motor function was altered, and specific effects were found on the presynaptic nerve terminals at the neuromuscular junction level, but not on the axonal tracts or myelin sheath integrity. Transcriptional markers of proteins involved in synaptic vesicle cycle were selectively altered, and the proteomic analysis showed that ACR-adducts were formed on cysteine residues of some synaptic proteins. Finally, analysis of neurotransmitters profile showed a significant effect on cholinergic and dopaminergic systems. These data support the suitability of the developed zebrafish model for screening of molecules with therapeutic value against this toxic neuropathy.
Original languageEnglish
Article number13952
JournalScientific Reports
Issue number1
Publication statusPublished - 1 Dec 2017


Dive into the research topics of 'Modelling acrylamide acute neurotoxicity in zebrafish larvae'. Together they form a unique fingerprint.

Cite this